The NM_000018.4(ACADVL):c.552del (p.Ile184fs) variant in ACADVL is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 8/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism ((PVS1; PMIDs 9973285, 11590124). At least one patient with this variant displayed Newborn Screening and follow-up data, which is highly specific for VLCAD. Specifically, a proband with this variant was identified via newborn screening to have C14:1 uM levels of 2.99 and asserted abnormal plasma acylcarnitine levels (PP4; PMID 24503138). This variant has been detected in at least 1 individual with very long chain acyl CoA dehydrogenase (VLCAD) deficiency. This individual is a compound heterozygous for the variant and a pathogenic variant (p.V283A) although the variants are not confirmed in trans. Based on ACADVL VCEP specific guidelines, a total of 0.5 points is awarded for criteria PM3 (PMID 24503138). This variant is absent from gnomAD v2.2.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PP4_moderate, PM3_supporting, PS2_supporting.) VCEP classification criteria version 2, 10/15/21.